Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
ClinicalTrials.gov study NCT03289273. IPD Sharing: UNDECIDED. Countries: 21. Publications: 0.
Biomolecular Analysis for Predicting Response to Regorafenib
ClinicalTrials.gov study NCT05759195. IPD Sharing: NO. Countries: 1. Publications: 0.
Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib
ClinicalTrials.gov study NCT03386825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
ClinicalTrials.gov study NCT07096609. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC
ClinicalTrials.gov study NCT04718909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
ClinicalTrials.gov study NCT06321055. IPD Sharing: NO. Countries: 1. Publications: 0.
Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）
ClinicalTrials.gov study NCT04806243. IPD Sharing: NO. Countries: 1. Publications: 0.
Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines
ClinicalTrials.gov study NCT01786538. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas
ClinicalTrials.gov study NCT03722108. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
ClinicalTrials.gov study NCT05394740. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
ClinicalTrials.gov study NCT03564938. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05462613. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
ClinicalTrials.gov study NCT06200363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer
ClinicalTrials.gov study NCT02664077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.
ClinicalTrials.gov study NCT02106845. IPD Sharing: Not stated. Countries: 2. Publications: 0.
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05985109. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC
ClinicalTrials.gov study NCT03347292. IPD Sharing: NO. Countries: 2. Publications: 0.
Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06454409. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib
ClinicalTrials.gov study NCT02800330. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
ClinicalTrials.gov study NCT04874207. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.